Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.

Gottlieb GS, Eholié SP, Nkengasong JN, Jallow S, Rowland-Jones S, Whittle HC, Sow PS.

AIDS. 2008 Oct 18;22(16):2069-72; discussion 2073-4. doi: 10.1097/QAD.0b013e32830edd44. No abstract available.

2.

Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.

Phillips AN, Walker AS.

AIDS. 2004 Feb 20;18(3):365-70. Review. No abstract available.

PMID:
15090787
3.

Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies.

Sabin CA, Phillips AN.

J Antimicrob Chemother. 2001 Apr;47(4):371-5. No abstract available.

PMID:
11266407
4.

Methodological issues of non-inferiority trials in HIV-infected patients: a need for consensus?

Richert L, Bouteloup V, Thiébaut R, Chêne G.

AIDS. 2008 May 11;22(8):996-7. doi: 10.1097/QAD.0b013e3282ff6490. No abstract available.

PMID:
18453863
5.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
6.

Antiretroviral therapy for patients with HIV disease.

Barry M, Mulcahy F, Back DJ.

Br J Clin Pharmacol. 1998 Mar;45(3):221-8. Review. No abstract available.

7.

Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection.

Menéndez-Arias L, Alvarez M.

Antiviral Res. 2014 Feb;102:70-86. doi: 10.1016/j.antiviral.2013.12.001. Epub 2013 Dec 15. Review.

PMID:
24345729
8.

Clinical trials of antiretroviral therapy in developing countries.

Clezy K, Emery S.

Aust N Z J Med. 2000 Feb;30(1):3-4. No abstract available.

PMID:
10800869
9.

Antiretroviral therapy of HIV infection. German-Austrian recommendations (July 2002).

German AIDS society.; Austrian AIDS society.; Drug Committee of the German Medical Board.; German Union of Registered Physicians for the Treatment of HIV and AIDS Patients.; German Cochrane Group.; German Surgical Association.; German Dermatological Association.; German Society of Infectiology.; German Society of Internal Medicine.; German Society of Hospital Hygiene.; German Society of Oromaxillofacial Surgery.; German Society of Pneumology.; German STD Association.; German Society of Tranfusion Medicine and Immune Haematology.; German Union Against Viral Diseases.; Antiviral Chemotherapy Commission of the Society of Virology.; German AIDS Help Association.; National Reference Centre for Retroviruses, Erlangen.; Robert Koch Institute..

Eur J Med Res. 2003 Jun 30;8(6):257-74. No abstract available.

PMID:
12918533
10.

Rapid progression of CD4 cell decline and subsequent response to salvage therapy in HIV-2 infection.

Houston SC, Miedzinski LJ, Mashinter LD.

AIDS. 2002 May 24;16(8):1189-91. No abstract available.

PMID:
12004281
11.
12.

Interleukin-2 in clinical trials: other factors to be considered.

Nannini EC.

J Infect Dis. 2001 Feb 15;183(4):679-80. No abstract available.

PMID:
11170999
13.

Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods.

Marcellin F, Spire B, Carrieri MP, Roux P.

Expert Rev Anti Infect Ther. 2013 Mar;11(3):239-50. doi: 10.1586/eri.13.8. Review.

PMID:
23458765
14.

Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

Rutherford GW, Sangani PR, Kennedy GE.

Cochrane Database Syst Rev. 2003;(4):CD002037. Review.

PMID:
14583945
15.

Decentralising HIV treatment in lower- and middle-income countries.

Kredo T, Ford N, Adeniyi FB, Garner P.

Cochrane Database Syst Rev. 2013 Jun 27;(6):CD009987. doi: 10.1002/14651858.CD009987.pub2. Review.

PMID:
23807693
16.

Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study.

Zinkernagel C, Ledergerber B, Battegay M, Cone RW, Vernazza P, Hirschel B, Opravil M.

AIDS. 1999 Aug 20;13(12):1587-9. No abstract available.

PMID:
10465088
17.

Experts plan to recommend immediate antiretroviral therapy for people with HIV.

O'Dowd A.

BMJ. 2015 Jun 1;350:h2963. doi: 10.1136/bmj.h2963. No abstract available.

PMID:
26033619
18.

One world, one hope: the cost of providing antiretroviral therapy to all nations.

Hogg RS, Weber AE, Craib KJ, Anis AH, O'Shaughnessy MV, Schechter MT, Montaner JS.

AIDS. 1998 Nov 12;12(16):2203-9.

PMID:
9833862
19.

Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trials.

Petersen ML, Wang Y, van der Laan MJ, Bangsberg DR.

J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S96-S103.

PMID:
17133209
20.

Uncertainty as to whether the use of antiretroviral therapy for persons recently infected with HIV has a favorable risk-to-benefit ratio.

Lundgren JD, Phillips AN, Neaton J.

Clin Infect Dis. 2009 Apr 15;48(8):1162; author reply 1162-3. doi: 10.1086/597495. No abstract available.

PMID:
19292638

Supplemental Content

Support Center